IFPMA Names President, New Members, R&D Commitments
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today announced that David Brennan of AstraZeneca will be its new president, replacing Haruo Naito of pharmaceutical companiy Eisai. They also announced that California-based biotechnology company Amgen has become a member.
